MYC and glioblastoma: Since c-Myc is a known master regulator of the Warburg-effect, controlling the expression of several key glycolytic genes, it was tempting to speculate whether Aurora kinase A inhibition would reduce the proliferation of GBM cells in a manner dependent on glycolysis, which is controlled by c-Myc.